Indication
Sickle cell disease
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S. Read more about Sickle cell disease
12 drugs 12 manufacturers
Drugs that treat it
Common Sickle cell disease therapies.
ENDARI (glutamine)
SIKLOS (hydroxyurea)
ADAKVEO (crizanlizumab-tmca)
DROXIA (hydroxyurea)
LYFGENIA (lovotibeglogene autotemcel)
CASGEVY (exagamglogene autotemcel)
XROMI (hydroxyurea)
L-GLUTAMINE (glutamine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S.
Under deoxygenated conditions, this abnormal hemoglobin polymerizes into rigid fibers, causing erythrocytes to distort into a crescent or sickle shape, lose flexibility, and undergo premature intravascular and extravascular hemolysis.
The impaired rheology of these deformed cells leads to microvascular occlusion, systemic endothelial inflammation, and tissue ischemia throughout the circulatory system.
Hallmarks include chronic hemolytic anemia, recurrent acute vaso-occlusive pain crises, increased susceptibility to encapsulated bacterial infections, and progressive multiorgan damage, such as acute chest syndrome and stroke.
- medlineplus.gov
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S
- cdc.gov
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S Hallmarks include chronic hemolytic anemia, recurrent acute vaso-occlusive pain crises, increased susceptibility to encapsulated bacterial infections, and progressive multiorgan damage, such as acute chest syndrome and stroke
- nih.gov
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S. Under deoxygenated conditions, this abnormal hemoglobin polymerizes into rigid fibers, causing erythrocytes to distort into a crescent or sickle shape, lose flexibility, and undergo premature intravascular and extravascular hemolysis The impaired rheology of these deformed cells leads to microvascular occlusion, systemic endothelial inflammation, an...
- pedsanesthesia.org
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S. Under deoxygenated conditions, this abnormal hemoglobin polymerizes into rigid fibers, causing erythrocytes to distort into a crescent or sickle shape, lose flexibility, and undergo premature intravascular and extravascular hemolysis The impaired rheology of these deformed cells leads to microvascular occlusion, systemic endothelial inflammation, an...
- nih.gov
Sickle cell disease is a group of inherited red blood cell disorders characterized by the production of abnormal hemoglobin, primarily hemoglobin S. Under deoxygenated conditions, this abnormal hemoglobin polymerizes into rigid fibers, causing erythrocytes to distort into a crescent or sickle shape, lose flexibility, and undergo premature intravascular and extravascular hemolysis
- medlineplus.gov
Hallmarks include chronic hemolytic anemia, recurrent acute vaso-occlusive pain crises, increased susceptibility to encapsulated bacterial infections, and progressive multiorgan damage, such as acute chest syndrome and stroke
- hematology.org
Hallmarks include chronic hemolytic anemia, recurrent acute vaso-occlusive pain crises, increased susceptibility to encapsulated bacterial infections, and progressive multiorgan damage, such as acute chest syndrome and stroke
Personalize your experience
Follow Sickle cell disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.